These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biologics as cancer treatment modalities. Smalley RV Wis Med J; 1987 Nov; 86(11):19-21. PubMed ID: 2447705 [No Abstract] [Full Text] [Related]
4. [Biological response modifiers and cancer treatment]. Urushizaki I Gan No Rinsho; 1989 Jan; Spec No():25-33. PubMed ID: 2464707 [No Abstract] [Full Text] [Related]
5. [Therapeutic potentials of cytokines and growth factors in severe infections]. van der Meer JW; Weening RS Ned Tijdschr Geneeskd; 1992 Jun; 136(24):1143-7. PubMed ID: 1376858 [No Abstract] [Full Text] [Related]
6. Cytokines and immunological monitoring. Kopp WC; Holmlund JT Cancer Chemother Biol Response Modif; 1996; 16():189-238. PubMed ID: 8639383 [No Abstract] [Full Text] [Related]
7. Biological response modifiers. Interferons, interleukins, and transfer factor. Kirkpatrick CH Ann Allergy; 1989 Mar; 62(3):170-6. PubMed ID: 2466425 [TBL] [Abstract][Full Text] [Related]
8. New antineoplastic therapies and inherent risks: monoclonal antibodies, biologic response modifiers and interleukin-2. Dillman JB J Intraven Nurs; 1989; 12(2):103-13. PubMed ID: 2475596 [TBL] [Abstract][Full Text] [Related]
9. [Recombinant blood hormones in clinical practice]. von dem Borne AE Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2068-72. PubMed ID: 2446154 [No Abstract] [Full Text] [Related]
10. Cytokines in the pathogenesis and treatment of infectious diseases. Lau AS Adv Pediatr Infect Dis; 1994; 9():211-36. PubMed ID: 7510110 [No Abstract] [Full Text] [Related]
12. New therapeutic modalities for cancer. Thomas H; Sikora K Acta Oncol; 1991; 30(1):107-20. PubMed ID: 1706927 [TBL] [Abstract][Full Text] [Related]
13. [Cellular growth factors in the treatment of bronchogenic cancers]. Pujol JL; Quantin X; Michel FB Rev Mal Respir; 1996; 13(4):335-8. PubMed ID: 8927788 [No Abstract] [Full Text] [Related]
14. The relevance of animal tumour models to the preclinical screening of cytokines. Kelly SA; Malik ST; Balkwill FR Cancer Surv; 1989; 8(4):741-54. PubMed ID: 2484311 [TBL] [Abstract][Full Text] [Related]
15. Immunological approaches to the treatment of malignant disease. Guillou PJ J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468 [No Abstract] [Full Text] [Related]
16. [Therapy and immunoprevention of HIV infection]. Vogt M; Lüthy R; Siegenthaler W Internist (Berl); 1988 Feb; 29(2):103-11. PubMed ID: 2453483 [No Abstract] [Full Text] [Related]
17. [Cytokines]. Almdahl SM Tidsskr Nor Laegeforen; 1988 Apr; 108(11):845-7. PubMed ID: 3287677 [No Abstract] [Full Text] [Related]
18. Biologic agents and approaches in the management of patients with lymphoma. A critical appraisal. Longo DL Hematol Oncol Clin North Am; 1991 Oct; 5(5):1067-87. PubMed ID: 1718939 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic properties of biological response modifiers. A discussion of preclinical and clinical studies. Talmadge JE Contrib Gynecol Obstet; 1989; 17():49-62. PubMed ID: 2495895 [No Abstract] [Full Text] [Related]